{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:53:00Z","timestamp":1781797980558,"version":"3.54.5"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00794","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T05:30:23Z","timestamp":1597210223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Kira","family":"von Bernuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Opitz-Welke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"B1","unstructured":"Health in prisons. A WHO guide to the essentials in prison health 2007"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2018.0808","article-title":"Medicine in the Penal System","volume":"115","author":"Opitz-Welke","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"B3","unstructured":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence 2009"},{"key":"B4","article-title":"Leitlinie der Deutschen Gesellschaft f\u00fcr Suchtmedizin: Therapie der Opiatabh\u00e4ngigkeit -Teil 1: Substitutionsbehandlung","author":"Backmund","year":"2014"},{"key":"B5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis","volume":"89","author":"Ma","year":"2018","journal-title":"Mol Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/add.12536","article-title":"The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"B7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/add.13193","article-title":"Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England","volume":"111","author":"Pierce","year":"2016","journal-title":"Addiction"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Systematic Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"J Subst Abuse Treat"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3172","article-title":"Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment","volume":"341","author":"Kimber","year":"2010","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004145.pub4","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","volume-title":"Cochrane Database Systematic Rev","author":"Gowing","year":"2011"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02249.x","article-title":"Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV\/AIDS","volume":"103","author":"Lawrinson","year":"2008","journal-title":"Addiction"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5694\/mja13.00153","article-title":"Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study","volume":"201","author":"White","year":"2014","journal-title":"Med J Aust"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1017\/s095026880900212x","article-title":"Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size","volume":"137","author":"Craine","year":"2009","journal-title":"Epidemiol Infection"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: a systematic review","volume":"107","author":"Hedrich","year":"2012","journal-title":"Addiction"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/add.13779","article-title":"Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England","volume":"112","author":"Marsden","year":"2017","journal-title":"Addiction"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30769-3","article-title":"Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners","volume":"388","author":"Kamarulzaman","year":"2016","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01050.x","article-title":"Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection","volume":"100","author":"Dolan","year":"2005","journal-title":"Addiction"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/1078345819837909","article-title":"The Global State of Harm Reduction in Prisons","volume":"25","author":"Sander","year":"2019","journal-title":"J Correctional Health Care"},{"key":"B22","unstructured":"Opioid substitution treatment in prison in EU 27, Coratia, Turkey and Norway2010"},{"key":"B23","unstructured":"Prevalence of lifetime injecting drug use among prisoners, 2000-2010 2012"},{"key":"B24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1186\/s12889-017-4840-4","article-title":"High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany","volume":"17","author":"Muller","year":"2017","journal-title":"BMC Public Health"},{"key":"B25","article-title":"Case of Wenner v. Germany, Application no. 62303\/13","year":"2016"},{"key":"B26","article-title":"Methadone versus torture: The perspective of the European Court of Human Rights. Heroin Addiction and Related Clinical Problems","author":"Junod","year":"2017"},{"key":"B27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/17449200802692144","article-title":"Substitution treatment and HCV\/HIV-infection in a sample of 31 German prisons for sentenced inmates","volume":"5","author":"Schulte","year":"2009","journal-title":"Int J Prisoner Health"},{"key":"B28","article-title":"DrogengebraucherInnen, Infektionen und Haft: Ergebnisse der Gef\u00e4ngnisstudie 2006\/2007 und vorl\u00e4ufige Ergebniss der DRUCK-Studie 2011-15 des RKI","volume-title":"HIV und Hepatitis-Pr\u00e4vention in Haft- keine Angst vor Spritzen","author":"Zimmermann","year":"2014"},{"key":"B29","article-title":"Bundeseinheitliche Datenerhebung zur stoffgebundenen Suchtproblematik im Justizvollzug","author":"Abraham","year":"2017"},{"key":"B30","article-title":"Substitutionsbehandlungen f\u0308r Opioidabh\u00e4ngige im Justiz- und Ma\u00dfregelvollzug","author":"St\u00f6ver","year":"2011"},{"key":"B31","article-title":"The State of Harm Reduction in Western Europe 2018","volume-title":"Harm Reduct Int","author":"Shirley-Beavan","year":"2019"},{"key":"B32","article-title":"National Report to the EMCDDA by the Reitox National Focal Point","volume-title":"Eur Monitor Centre Drugs Addict Deutsche Beobachtungsstelle F\u00fcr Drogen Und Drogensucht","author":"Pfeiffer-Gerschel","year":"2011"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/17449200600743396","article-title":"Substitution treatment in European prisons: A study of policies and practices in 18 European countries","volume":"2","author":"St\u00f6ver","year":"2006","journal-title":"Int J Prisoner Health"},{"key":"B34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-0032-1311600","article-title":"Drogenabh\u00e4ngige in Haft - Epidemiologie, Pr\u00e4vention und Behandlung in Totalen Institutionen","volume":"13","author":"St\u00f6ver","year":"2012","journal-title":"Suchttherapie"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/15332640.2014.886320","article-title":"Barriers to drug abuse treatment for Latino migrants: treatment providers\u2019 perspectives","volume":"13","author":"Pagano","year":"2014","journal-title":"J Ethn Subst Abuse"},{"key":"B36","article-title":"Asian-Americans, Addiction, and Barriers to Treatment","volume":"4","author":"Fong","year":"2007","journal-title":"Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00538","article-title":"Yield and Efficiency of Mental Disorder Screening at Intake to Prison: A Comparison of DIA-X Short- and Long-Screening-Protocols in Compensation Prisoners","volume":"9","author":"Schildbach","year":"2018","journal-title":"Front Psychiatry"},{"key":"B38","article-title":"The ICD-10 Classification of Mental and Behavioural Disorders","volume-title":"Clin Descript Diagn Guidelines","year":"2016"},{"key":"B39","article-title":"Abschlussbericht der Studie \u201cDrogen und chronische Infektionskrankheiten in Deutschland\u201d (DRUCK-Studie)","year":"2016"},{"key":"B40","unstructured":"Die Drogenbeauftragte der Bundesregierung, Bundesministerium f\u00fcr Gesundheit. Drogen- und Suchtbericht2018"},{"key":"B41","article-title":"Lebenslange Freiheitsstrafe und Sicherungsverwahrung","author":"Dessecker","year":"2013"},{"key":"B42","volume-title":"Die Vollstreckung lebenslanger Freiheitsstrafen: Dauer und Gr\u00fcnde der Beendigung im Jahr 2015","author":"Dessecker","year":"2017"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1348\/0007-1102.002003","article-title":"A closer look at the effect of preliminary goodness-of-fit testing for normality for the one-sample t-test","volume":"64","author":"Rochon","year":"2011","journal-title":"Br J Math Stat Psychol"},{"key":"B44","article-title":"Annual Report 2012- the State of the Drugs Problem in Europe","year":"2012"},{"key":"B45","unstructured":"Merkmale der Strafgefangenen und Sicherungsverwahrten in Berlin2018"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2019.0137","article-title":"Estimation of the Number of People With Opioid Addiction in Germany","volume":"116","author":"Kraus","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.17886\/EpiBull-2018-016","article-title":"Gro\u00dfe Unterschiede bei TB-, HIV-, HVC-Behandlung und Opioid-Substitutions-Therapie unter Gefangenen in Deutschland","author":"Schmidt","year":"2018","journal-title":"Epidemiol Bull"},{"key":"B48","unstructured":"Drogen- und Suchtbericht2018"},{"key":"B49","article-title":"Selected Issues","volume-title":"Prisons and Drugs in Europe: The Problem and Responses","year":"2012"},{"key":"B50","doi-asserted-by":"publisher","first-page":"w13898","DOI":"10.4414\/smw.2013.13898","article-title":"Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland","volume":"143","author":"Favrod-Coune","year":"2013","journal-title":"Swiss Med Wkly"},{"key":"B51","article-title":"Differential indications for the use of the various substitution products and their therapeutic dosage","volume-title":"Development and Improvement of Substitution Programs Council of Europe","author":"Wolstein","year":"2001"},{"key":"B52","article-title":"Substitutionsbehandlung im Strafvollzug","author":"Pont","year":"2018"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: Lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug Alcohol Dependence"},{"key":"B54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000320576","article-title":"Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians","volume":"17","author":"Stover","year":"2011","journal-title":"Eur Addict Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addbeh.2015.02.016","article-title":"Treating substance abuse is not enough: Comorbidities in consecutively admitted female prisoners","volume":"46","author":"Mir","year":"2015","journal-title":"Addictive Behav"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.1007\/3-540-28447-8_16","article-title":"Gef\u00e4ngnismedizin im Frauenvollzug","volume-title":"Intramurale Medizin-Gesundheitsf\u0308rsorge zwischen Heilauftrag und Strafvollzug","author":"Keppler","year":"2005"},{"key":"B57","first-page":"29","article-title":"Rechtliche Grundlagen","volume-title":"Gef\u00e4ngnismedizin: medizinische Versorgung unter Haftbedingungen; 18 Tabellen","author":"Feest","year":"2009"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"Dolan","year":"2016","journal-title":"Lancet"},{"key":"B59","article-title":"Erratum zu: Psychische St\u00f6rungen in der Allgemeinbev\u00f6lkerung","author":"Jacobi","year":"2016"},{"key":"B60","first-page":"193","article-title":"Behandlungsm\u00f6glichkeiten von Opiatabh\u00e4ngigkeit","volume-title":"Gef\u00e4ngnismedizin: medizinische Versorgung unter Haftbedingungen; 18 Tabellen","author":"Keppler","year":"2009"},{"key":"B61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13011-020-00262-w","article-title":"Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach","volume":"15","author":"Bohmer","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1477-7517-7-17","article-title":"Drug use and opioid substitution treatment for prisoners","volume":"7","author":"St\u00f6ver","year":"2010","journal-title":"Harm Reduct J"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00794\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T05:30:31Z","timestamp":1597210231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00794\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":62,"alternative-id":["10.3389\/fpsyt.2020.00794"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00794","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"article-number":"794"}}